Hospital Corporation of China Limited ("Hospital Corp." or the "Company", stock code: 3869.HK) was successfully listed on the Main Board of the Stock Exchange of Hong Kong on March 16, 2017. CICC acted as Sole Sponsor, Sole Global Coordinator, Sole Bookrunner and Sole Lead Manager.

The total number of shares offered before green-shoe was 33.334 million shares, representing 25.0% of the Company’s pre green-shoe share capital, raising USD54.977 million; the total number of shares offered after green-shoe was 38.334 million shares, representing 27.7% of the Company’s post green-shoe share capital, raising USD63.223 million; the offering price was HKD12.80 per share. International Placing was over-subscribed and HKPO received approximately 3.6 times subscription.

Hospital Corporation of China is a specialized hospital operation management group. The transaction is the first IPO on the Hong Kong market by a hospital management group with management and operation of comprehensive non-profit hospitals as its main business. Based on deep understanding of the private hospital industry and the client, CICC fully tapped into the investment highlights of the Company; assisted the client in its debut on the capital market and crafting its investment story; won the precious listing and financing platform for the client to grasp the rapid development opportunities in private hospital industry.

Since the end of 2016, CICC has completed Hong Kong IPO for three hospitals. CICC has won the leadership position in the healthcare sector of the Hong Kong IPO market with its professionalism and reputation in the industry, which will help CICC seize more opportunities in this industry.